China is holding America’s medicine cabinets to ransom, a new report warns

Specialties: The threat from China may be closer to home than most Americans realize — sitting in their bathroom cabinets. A new report warns that the US’s dependence on Chinese-made drugs leaves the country vulnerable and suggests a possible solution: strengthening friendships, or learning to rely on allies rather than adversaries.

The US Israel Education Association (USIAEA) recently released a report warning that “foreign nations are holding America’s medicine cabinets to ransom.” This includes China, which plays an important role in the US Medical Supply chain as 41% of the sourcing materials (KSMS) used in the US active pharmaceutical ingredients (API) are sourced exclusively from China.

Additionally, the report notes that “China is the only KSM for at least one of KSM’s 679 APIs, accounting for 37% of all APIs,” which puts the American consumer at greater risk. The USIA points out that the current US health care system puts price before safety and equates to “playing Russian Roulette” with bad actors.

The Aff Chain Ai company is sounding the alarm about America’s reliance on Chinese medicine

“About 90 percent – including pharmacies, for example, that we use here in the United States in volume are generic drugs, and that are produced one day that we can send political products for political reasons … FDA Associate Commissioner and USIA ONEAE SENIOR SENATION BETE PETTS told FOX Business.

The USIA report points to the Covil-19 pandemic as a prime example of the risks to the US Pharmaceutical Supply Chain and how its credibility in China can be compromised. During the pandemic, the US found a shortage of contrast agents, which medical professionals use to improve the visibility of body parts, blood vessels and tissues in X-rays, CT Scans and MRIS. The report notes that by 2022, the manufacturer’s largest manufacturing facility near Shanghai will close due to the lockdown, causing unrest in the US

“Here at home, this has led to significant reductions in angiograms, cold scans and other tests important to stroke screening, cancer diagnoses, and other emergency medical care,” the report said. “This one plant in China almost always supplies the agent used in the United States. It’s not hard to imagine supplies for diabetes or ADHD drugs, or penicillin driven for geopolitical purposes.”

The issue, however, predicts an epidemic. The USIA report reports an example in 2008 when an anticondad anticoagulant from China killed 81 people and left 785 seriously injured.

The FDA’s understanding of Chinese manufacturing is also limited and highly regulated, creating what Shiya saw as a “recipe for disaster.”

As the report explains, when inspectors are required to notify the site ahead of time, “production logs are changed, factory ingredients are cleaned, and access to many important areas is restricted.”

Torasemid al high quality tablets from a 2090i machine by a 2090i machine, manufactured by Fette GmbH, Stada Arzneimittel Ag Pharmaceutical Factory in Bad Vilbel, Germany. (Krisztic Bocsi/Bloomberg)

Trump’s Top Adviser Says New Tariffs Are Designed to End China’s Grip on the US Workwet Chain

The organization is putting forward a solution that has already received some recognition in Washington – the establishment of the Office of the FDA Abraham acconcs. The report describes the office as a “regional regulatory deployment” that will serve as an extension of the FDA “with three priorities: Economic security, communication leadership.

The purpose of the FDA office Abraham Abraham, according to the report, would be “to create institutions to separate friendships, to give the power to change the supply chains of important drugs by working with reliable partners while observing the FDA. This will allow the US to change its reliance on high-ranking countries, such as China, to friendly people, such as Israel, the United Arab Emirates, Bahrain and Morocco.

A bipartisan bill that has passed the house has a provision to create an FDA Abraham acconcs office. This bill, known as HR1262, or “Mikaela Naylon giving children a chance at law,” was introduced by Rep. Michael McCaul, R-Texas, in February and has bipartisan sponsors. According to the law, the office will not approve drugs, instead it would work as a liaison between the FDA and manufacturers in the Abraham Account Nations.

USIA points out that Abraham acknowledges that they are “trusted partners who share regulatory standards and political alignment.”

“The countries of Abraham have decided to look to the 21st century … Therefore, it has given this opportunity to expand the area of ​​the world,” United’s policy director, especially EJ Kimball told Fox Business.

However, the strategy of shaking a friend is as effective as it is political, as Kimball, the Pitts and the USIA say that Abraham Counts Nitions is ready to fulfill the pharmaceutical needs of the US.

“[Israel and the United Arab Emirates] they are two very stable things that have made great progress in various areas, not least of which is development and execution, “said Pitts.” They punch well above their weight in these spaces. “

Workers work on a production line for xiaoQinglong capsules, a cough medicine, at a factory in 2023 in Shenyang, China. (VCG via Getty Images)

Abraham activect Argenct says it is the first time in decades that he has had hope for the Middle East

The push to expand cooperation with Abraham congron Nations is about getting American goods sold; It would also allow the US to get a head start on China’s influence. Kimball warns that China has been hard at work trying to deepen its presence in the Middle East. However, he and Pitts believe that by adding Abraham to their relationship, the US can stop China in its tracks.

“Morocco was very clear to us that they want to work with the United States, and China is knocking on their door. And they are working with the threat that they will not be affected by the time,” but they will only be China when they will appreciate it more,” said Kimball.

Pitts was struck by US administrations accond’s “giving the cold shoulder” to potential partners around the world without thinking about the consequences. However, he believes that we are still attracted to countries in China.

Hard capsules containing the drug “GripPostad” are produced at the headquarters of the pharmaceutical manufacturer Stada in Bad Vilbel. (Boris Roesreler / Photo Alliance via Getty Images)

Get fox business on the go with a click HERE

“As soon as we open our arms and say we want to do business with countries we trust, with countries that value technological development for non-military reasons and with countries that win,” said Pitts.

USIA proves that moving the supply chain of nations, like those in Abraham, is not only a good move but an important action to protect national security. As the report puts it, “In a country where disruptions in supply can threaten the country’s military stability, ensuring access to essential medicines is an act of sovereignty.”